IDEX Biometrics ASA

LSE:0MTP UK
Market Cap
$509.63 Million
Nkr5.81 Billion NOK
Market Cap Rank
#21932 Global
#401 in UK
Share Price
Nkr10.70
Change (1 day)
-5.91%
52-Week Range
Nkr5.25 - Nkr12.20
All Time High
Nkr12.20
About

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless smart cards that includes financial payment, access control, and digital identity, as well as card-based de… Read more

IDEX Biometrics ASA (0MTP) - Net Assets

Latest net assets as of September 2025: Nkr26.34 Million NOK

Based on the latest financial reports, IDEX Biometrics ASA (0MTP) has net assets worth Nkr26.34 Million NOK as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr81.75 Million) and total liabilities (Nkr55.41 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Nkr26.34 Million
% of Total Assets 32.22%
Annual Growth Rate 1.58%
5-Year Change -62.34%
10-Year Change -94.47%
Growth Volatility 124.51

IDEX Biometrics ASA - Net Assets Trend (2004–2024)

This chart illustrates how IDEX Biometrics ASA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for IDEX Biometrics ASA (2004–2024)

The table below shows the annual net assets of IDEX Biometrics ASA from 2004 to 2024.

Year Net Assets Change
2024-12-31 Nkr4.71 Million -58.55%
2023-12-31 Nkr11.37 Million -50.22%
2022-12-31 Nkr22.84 Million -39.45%
2021-12-31 Nkr37.73 Million +201.46%
2020-12-31 Nkr12.51 Million -29.43%
2019-12-31 Nkr17.73 Million +25.37%
2018-12-31 Nkr14.15 Million -65.54%
2017-12-31 Nkr41.05 Million -36.90%
2016-12-31 Nkr65.05 Million -23.72%
2015-12-31 Nkr85.28 Million +160.56%
2014-12-31 Nkr32.73 Million +299.04%
2013-12-31 Nkr8.20 Million +150.00%
2012-12-31 Nkr3.28 Million +1.12%
2011-12-31 Nkr3.24 Million +98.63%
2010-12-31 Nkr1.63 Million +215.56%
2009-12-31 Nkr-1.41 Million -0.81%
2008-12-31 Nkr-1.40 Million -929.72%
2007-12-31 Nkr-136.16K -107.29%
2006-12-31 Nkr1.87 Million +266.12%
2005-12-31 Nkr510.12K -85.19%
2004-12-31 Nkr3.44 Million --

Equity Component Analysis

This analysis shows how different components contribute to IDEX Biometrics ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 34447800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock Nkr12.94 Million 274.60%
Other Components Nkr336.25 Million 7134.50%
Total Equity Nkr4.71 Million 100.00%

IDEX Biometrics ASA Competitors by Market Cap

The table below lists competitors of IDEX Biometrics ASA ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IDEX Biometrics ASA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 11,369,806 to 4,713,000, a change of -6,656,806 (-58.5%).
  • Net loss of 14,449,000 reduced equity.
  • Other comprehensive income decreased equity by 314,280,764.
  • Other factors increased equity by 322,072,958.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Nkr-14.45 Million -306.58%
Other Comprehensive Income Nkr-314.28 Million -6668.38%
Other Changes Nkr322.07 Million +6833.71%
Total Change Nkr- -58.55%

Book Value vs Market Value Analysis

This analysis compares IDEX Biometrics ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 943.04x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 283.83x to 943.04x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 Nkr0.04 Nkr10.70 x
2005-12-31 Nkr0.01 Nkr10.70 x
2006-12-31 Nkr0.02 Nkr10.70 x
2007-12-31 Nkr0.00 Nkr10.70 x
2008-12-31 Nkr-0.02 Nkr10.70 x
2009-12-31 Nkr-0.02 Nkr10.70 x
2010-12-31 Nkr0.01 Nkr10.70 x
2011-12-31 Nkr0.01 Nkr10.70 x
2012-12-31 Nkr0.01 Nkr10.70 x
2013-12-31 Nkr0.13 Nkr10.70 x
2014-12-31 Nkr0.40 Nkr10.70 x
2015-12-31 Nkr0.93 Nkr10.70 x
2016-12-31 Nkr0.61 Nkr10.70 x
2017-12-31 Nkr0.38 Nkr10.70 x
2018-12-31 Nkr0.13 Nkr10.70 x
2019-12-31 Nkr0.15 Nkr10.70 x
2020-12-31 Nkr0.08 Nkr10.70 x
2021-12-31 Nkr0.21 Nkr10.70 x
2022-12-31 Nkr0.11 Nkr10.70 x
2023-12-31 Nkr0.04 Nkr10.70 x
2024-12-31 Nkr0.01 Nkr10.70 x

Capital Efficiency Dashboard

This dashboard shows how efficiently IDEX Biometrics ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -306.58%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1718.07%
  • • Asset Turnover: 0.08x
  • • Equity Multiplier: 2.18x
  • Recent ROE (-306.58%) is below the historical average (-161.22%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 -64.43% 0.00% 0.00x 1.13x Nkr-2.56 Million
2005 -655.15% 0.00% 0.00x 2.00x Nkr-3.39 Million
2006 -295.73% -29640.51% 0.01x 1.63x Nkr-5.71 Million
2007 0.00% 0.00% 0.00x 0.00x Nkr-6.17 Million
2008 0.00% -81311.59% 0.00x 0.00x Nkr-2.89 Million
2009 0.00% -919503.78% 0.00x 0.00x Nkr-4.62 Million
2010 -290.83% -42317.38% 0.00x 1.62x Nkr-4.91 Million
2011 -192.89% -37732.89% 0.00x 1.36x Nkr-6.58 Million
2012 -182.14% -3189.77% 0.04x 1.37x Nkr-6.30 Million
2013 -130.31% -928642.14% 0.00x 1.52x Nkr-11.51 Million
2014 -50.59% -8651.25% 0.00x 1.23x Nkr-19.83 Million
2015 -30.52% -65567.99% 0.00x 1.10x Nkr-34.56 Million
2016 -36.14% -527.16% 0.06x 1.08x Nkr-30.02 Million
2017 -75.80% -1593.20% 0.04x 1.10x Nkr-35.22 Million
2018 -213.71% -12075.96% 0.01x 1.27x Nkr-31.64 Million
2019 -182.81% -20482.04% 0.01x 1.32x Nkr-34.19 Million
2020 -213.76% -2442.92% 0.06x 1.36x Nkr-28.00 Million
2021 -86.28% -1146.13% 0.07x 1.12x Nkr-36.32 Million
2022 -142.99% -798.14% 0.14x 1.27x Nkr-34.94 Million
2023 -234.95% -643.37% 0.17x 2.20x Nkr-27.85 Million
2024 -306.58% -1718.07% 0.08x 2.18x Nkr-14.92 Million

Industry Comparison

This section compares IDEX Biometrics ASA's net assets metrics with peer companies in the same industry.

Industry Context

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
IDEX Biometrics ASA (0MTP) Nkr26.34 Million -64.43% 2.10x $42.98 Million
Nyfosa AB (0A0K) $2.92 Billion 39.50% 2.88x $973.31 Million
High Templar Tech Limited (0A2T) $12.52 Billion 4.70% 0.13x $255.82 Million
Strategy Inc (0A7O) $51.04 Billion -7.54% 0.21x $40.17 Billion
NACON SASU (0A9N) $67.54 Million 15.85% 1.20x $7.64 Million
Antin Infrastructure Partners (0AA5) $23.79 Million 108.98% 1.09x $573.10 Million
Truecaller AB Series B (0AA7) $1.41 Billion 18.30% 0.20x $281.60 Million
Brockhaus Technologies AG (0AAW) $254.92 Million -6.23% 1.68x $74.40 Million
Hyloris Pharmaceuticals S.A. (0AB6) $48.06 Million -24.09% 0.32x $71.96 Million
Kalray S.A. (0ABT) $28.43 Million -41.56% 0.67x $33.84 Million
Webuild S.p.A. (0BJP) $1.43 Billion 10.29% 7.14x $1.13 Billion